Cardlytics (CDLX) Stock Statistics & Valuation Metrics

Cardlytics has a market cap or net worth of $367.60M. The enterprise value is $207.87.

Cardlytics has 5,807,863 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cardlytics’s return on equity (ROE) is 15.90 and return on invested capital (ROIC) is -22.57%.

The current PE Ratio of Cardlytics is ―. Cardlytics’s PEG ratio is 0.01.

In the last 12 months, Cardlytics had revenue of 233.27M and earned -103.49M in profits. Earnings per share was -19.50.

In the last 12 months, operating cash flow was 10.35M and capital expenditures -11.45M, giving a free cash flow of -1.07M billion.

Cardlytics pays an annual dividend of ―, resulting in a dividend yield of ―

Cardlytics upcoming earnings date is Aug 5, 2026, After Close (Confirmed).

Cardlytics as a current ratio of 1.75, with Debt / Equity ratio of -5246.76%

In the past 12 months, Cardlytics has paid 0.00 in taxes.

Cardlytics EV to EBITDA ratio is -3.48, with an EV/FCF ratio of -35.07.

Cardlytics has $59.80M in cash and marketable securities with $210.03M in debt, giving a net cash position of -$150.22M billion.

Gross margin is 46.96%, with operating margin of -20.21%, and net profit margin of -44.36%.

The average price target for Cardlytics is ―, which is 11.43% higher than the current price. The consensus rating is ―